000 | 01924 a2200505 4500 | ||
---|---|---|---|
005 | 20250515121937.0 | ||
264 | 0 | _c20080710 | |
008 | 200807s 0 0 eng d | ||
022 | _a0065-2598 | ||
024 | 7 |
_a10.1007/978-0-387-69080-3_53 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLapouge, Gaëlle | |
245 | 0 | 0 |
_aSpecific properties of a C-terminal truncated androgen receptor detected in hormone refractory prostate cancer. _h[electronic resource] |
260 |
_bAdvances in experimental medicine and biology _c2008 |
||
300 |
_a529-34 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aErbB Receptors _xantagonists & inhibitors |
650 | 0 | 4 | _aGene Expression Regulation, Neoplastic |
650 | 0 | 4 | _aGenetic Variation |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aMAP Kinase Kinase 1 _xantagonists & inhibitors |
650 | 0 | 4 |
_aMAP Kinase Kinase 2 _xantagonists & inhibitors |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aNF-kappa B _xgenetics |
650 | 0 | 4 |
_aNFATC Transcription Factors _xgenetics |
650 | 0 | 4 |
_aNeoplasms, Hormone-Dependent _xgenetics |
650 | 0 | 4 |
_aPhosphatidylinositol 3-Kinases _xmetabolism |
650 | 0 | 4 | _aPhosphoinositide-3 Kinase Inhibitors |
650 | 0 | 4 | _aPhosphorylation |
650 | 0 | 4 |
_aProstatic Neoplasms _xgenetics |
650 | 0 | 4 |
_aReceptors, Androgen _xgenetics |
650 | 0 | 4 |
_aTranscription Factor AP-1 _xgenetics |
650 | 0 | 4 | _aTranscription, Genetic |
650 | 0 | 4 | _aTranscriptional Activation |
650 | 0 | 4 | _aTumor Cells, Cultured |
700 | 1 | _aMarcias, Gemma | |
700 | 1 | _aErdmann, Eva | |
700 | 1 | _aKessler, Pascal | |
700 | 1 | _aCruchant, Marion | |
700 | 1 | _aSerra, Sebastian | |
700 | 1 | _aBergerat, Jean-Pierre | |
700 | 1 | _aCéraline, Jocelyn | |
773 | 0 |
_tAdvances in experimental medicine and biology _gvol. 617 _gp. 529-34 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/978-0-387-69080-3_53 _zAvailable from publisher's website |
999 |
_c17990950 _d17990950 |